JPMA to Call on Its Member Companies to Ask Lecturers at Seminars Sponsored by Them for Their Permission to Disclose COI-Related Information

At a meeting of its board of directors in Osaka on April 18, the Japan Pharmaceutical Manufacturers Association (JPMA) reported on its response to requests from the Japan Medical Association (JMA) and the Japanese Association of Medical Sciences (JAMS) regarding...read more